Brainstorm Cell Therapeut... (BCLI)
NASDAQ: BCLI
· Real-Time Price · USD
0.63
0.03 (5.00%)
At close: Aug 15, 2025, 3:47 PM
0.61
-2.38%
After-hours: Aug 15, 2025, 03:47 PM EDT
5.00% (1D)
| Bid | 0.61 |
| Market Cap | 6.2M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -11.09M |
| EPS (ttm) | -2.01 |
| PE Ratio (ttm) | -0.31 |
| Forward PE | -0.62 |
| Analyst | Buy |
| Ask | 0.63 |
| Volume | 5,629 |
| Avg. Volume (20D) | 1,378,375 |
| Open | 0.62 |
| Previous Close | 0.60 |
| Day's Range | 0.60 - 0.63 |
| 52-Week Range | 0.52 - 6.00 |
| Beta | 0.11 |
About BCLI
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol BCLI
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for BCLI stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts4 weeks ago
-28.21%
BrainStorm Cell Therapeutics is trading lower afte...
Unlock content with
Pro Subscription
4 weeks ago
-2.5%
BrainStorm Cell Therapeutics is trading lower after receiving a delisting notice from Nasdaq effective July 18, 2025.
2 months ago · seekingalpha.com
Brainstorm Cell Therapeutics Inc. (BCLI) Q1 2025 Earnings Call TranscriptBrainstorm Cell Therapeutics Inc. (NASDAQ:BCLI ) Q1 2025 Earnings Conference Call May 19, 2025 8:30 AM ET Company Participants Joyce Lonergan - Investor Relations, LifeSci Advisors Chaim Lebovits - Pr...